Diagnostics Dialogues

Diagnostics is the thread that connects the entire healthcare ecosystem and patient care continuum. And the laboratory generates an immense amount of data that can help enable improvements in both patient and hospital health. By better leveraging laboratory analytics, health systems and clinicians can identify, stratify, and prioritize patient populations to improve their health and the overall quality of care. In this session, Dr Waheed and Dr Hilborne discuss: System-level strategies that can deliver meaningful, credible data to clinicians to align goals and drive meaningful, collaborative discussions across your health systems Change management approaches that can bring together physicians, patients, laboratorians, and other key stakeholders to drive effective test utilization strategies and reduce physician burnout Ways to approach and exercise leadership around the concept of lab stewardship within the overall delivery of care, as well as practice of pathology and laboratory medicine Opportunities to leverage Quest’s vast patient-centric data set to inform standard of care expectations, risk stratification, and healthy equity improvements   Rehan Waheed, MD Senior Medical Director & Chief Medical Informatics Officer, Healthcare Analytics Solutions, Quest Diagnostics Dr Rehan Waheed joined Quest Diagnostics in 2021 as Senior Medical Director & Chief Medical Informatics Officer for Healthcare Analytics Solutions. In this leadership role at the critical intersection of medicine, informatics, and business, he oversees clinical expertise for Quest’s healthcare analytics solutions while also championing important initiatives to advance analytics in public health. Dr Waheed is an advocate for action, leverages knowledge from other industries and is a proponent of value-based, patient-centered healthcare leveraging health information technology. Prior to joining Quest, Dr Waheed was a Director at Cerner Corporation leading efforts in the federal sector. Other past roles include Sr. Director in the Department of Integration & Transformation (DoIT) at The MetroHealth System, Sr. Consultant for Better Health Partnership, and Medical Officer at the Louis Stokes Cleveland VA Medical Center. He is board-certified in Internal Medicine, he has a Lean Six Sigma Black Belt, Informatics Certificate and Emotionally Intelligent Leadership Certificate from CWRU Weatherhead School of Management. He continues to teach as an adjunct faculty at Baldwin Wallace and guest lecturer for other universities. Lee H. Hilborne, MD, MPH Professor of Pathology and Laboratory Medicine, UCLA Senior National Medical Director, Quest Diagnostics  Dr Hilborne is Professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA; Senior National Medical Director for Quest Diagnostics; and a Health Services Researcher at the RAND Corporation in Santa Monica. Dr Hilborne served as a member of the ASCP Board of Directors for 18 years, was president from 2007-2008 and, for nine years, was a member of the Board of Governors for ASCP’s Board of Certification. He chairs the ASCP Effective Test Utilization Subcommittee and is a member of the Commissions on Membership and Public Policy. For the past eight years, Dr Hilborne has been a member of Venice Family Clinic’s Medical Practice Committee. 

The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic. In this session, Dr Gudin discusses: Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations  Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuse System-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations Jeffrey Gudin, MD; Executive Director, Medical Affairs, Drug Monitoring & Toxicology Dr Gudin is an active speaker and advisor whose clinical and research interests include postoperative pain management; opioid abuse, and potential solutions; and increasing clinical awareness of pain assessment and risk management. Board-certified in pain management, addiction medicine, and hospice and palliative medicine, Dr Gudin is also a medical acupuncturist. He serves as co-Editor-at-Large for Practical Pain Management.

This episode features Dr Michael Racke discussing the evolution of treating neurologic disease to detect disease early and focus on prevention.  In this session, Dr Racke discusses: How diagnostics and treatment has evolved for multiple sclerosis Treating patients at the first incidence of neurologic disease for optimal outcomes How health systems can address the needs of patients with complex neurologic conditions to minimize the human and economic toll of disease Michael Racke MD Bio:   Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. Dr Racke is a leader in the field of neurology and neuroimmunology. Dr Racke is the author of more than 200 peer-reviewed papers, book chapters, and reviews spanning the pathogenesis of neuroimmunologic diseases. He continues to serve on several national professional society committees.

  This episode features Yuri Fesko MD, with clinical pathways to help guide diagnosis and treatment in oncology. In this session, Dr Fesko discusses: How clinical pathways can make an impact for hospitals to improve oncology outcomes The critical importance of collaboration for pathologists and oncologists The future of oncology care in integrated health systems Yuri Fesko MD Bio: Dr Yuri Fesko serves as the Executive Medical Director of Medical Affairs at Quest Diagnostics, and the Chief Clinical Officer for Oncology Strategic Collaboration at Quest. Born and raised in New York City, Dr Fesko trained at Case Western Reserve University, and completed his fellowship at University Hospitals of Cleveland. After his fellowship, Dr Fesko served as the Chief of Community Oncology for Wake County through Duke University Health System.An experienced oncologist and medical business leader, he is currently responsible for strategic clinical development at Quest across multiple functional areas including Regulatory FDA, HEOR, and R&D.

Today’s podcast features Dr Nicholaos Bellos with strategies that are helping some health systems best operate in today's healthcare environment. In this session, Dr Bellos discusses: The ease of viral transmission and what health systems can do to mitigate risk Diagnostic solutions, guidelines, and best practices to ensure safety for the front line The future of health systems in the post-pandemic landscape Nicholaos Bellos MD Bio: Board-certified in internal medicine and infectious disease, Dr Nicholaos Bellos brings both deep clinical knowledge and executive leadership experience to the discussion. Drawing from his passion for advancing positive outcomes for patients, his expertise includes delivering evidence-based, measurable healthcare solutions that contain costs, reduce hospital length-of-stay and readmissions, and cut down on hospital-acquired drug-resistant infections. Dr Bellos maintains a private clinical practice of over 20 years, as well as serving as national medical director, extended care services at Quest Diagnostics. Previously, he was associate vice president of medical operations and performance management and innovation at Tenet Health.

When we asked Dr. Alagia his goals for this podcast, he told us, "I think the podcast project gives our doctors and our scientists at Quest a voice. It connects us with the outside community. We work with a lot of folks who live in the laboratories, who live in the hospitals, who do great work here. It's essential work. Everything starts with the lab. We can't treat a patient without laboratorians and all the work that they do. We wanted to make sure that people understood how number one, important they are, but how powerful their intellects are in terms of contributing to patient care. Without them, everything stops."  He then added, "One of the things that's important for us to talk about is care, science, and community. When people hear that it's not just the testing and the analytics and everything else that we do and the insights that we provide, but really at the core of everything we do is patient care, and that's what our north star is. That's what drives us." We are glad to welcome you to Diagnostics Dialogues from Quest Diagnostics. Be sure to subcribe.